REFERENCES
- Mariotti SP, Pascolini D, Rose-Nussbaumer J. Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009;93:563–568
- World Health Assembly. Global elimination of blinding trachoma. 51st World_Health_Assembly, Geneva 16 May 1998 resolution. WHA51.11
- Solomon AW, Kurylo E. The Global Trachoma Mapping Project. J Community Eye Health 2014;27(85):18
- Taylor HR, Munoz EC, Ruvalcaba AM, et al. Trachoma in Chiapas, Mexico. Rev Int Trach Path Ocul Trop Subtrop Sante Publique 1983:17–27
- Medina NH, Oliveira MB, Tobin S, et al. The prevalence of trachoma in preschool and school children in Olimpia, Guaraci and Cajobi, Sao Paulo, Brazil. Trop Med Parasitol 1992;43:121–123
- Cruz AA, Medina NH, Ibrahim MM, et al. Prevalence of trachoma in a population of the upper Rio Negro basin and risk factors for active disease. Ophthalmic Epidemiol 2008;15:272–278
- Thylefors B, Dawson C, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987;65:477–483
- Munoz B, Mkocha H, Gaydos C, et al. Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 2011;52:8806–8810
- Keenan JD, Lakew T, Alemayehu W, et al. Slow resolution of clinically active trachoma following successful mass antibiotic treatments. Arch Ophthalmol 2011;129:512–513
- Last AR, Burr SE, Weiss HA, et al. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naive trachoma-hyperendemic communities of the Bijagos Archipelago, Guinea Bissau. PLoS Negl Trop Dis 2014;8:e2900
- Munoz BE, Mkocha H, West SK. Estimating trachoma prevalence at the district level using CRS Methodology. How many clusters are enough? Invest Ophthalmol Vis Sci 2010;51:E-Abstract 1316